SCHEMBL19804308

SCHEMBL19804308

C=C(C)C(=O)OCCOc1cc(-c2ccc(-c3ccccc3)cc2F)ccc1CCO

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 2/20 0.40
FEN1 P39748 2/20 0.40
LTB4R Q15722 3/20 0.38
LTB4R2 Q9NPC1 3/20 0.38
SLC6A9 P48067 3/20 0.38
EGFR P00533 1/20 0.38
PTGS1 P23219 4/20 0.36
PGR P06401 1/20 0.36
PDE4A P27815 1/20 0.36
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 2/20 0.34
PTGS2 P35354 2/20 0.34
KMT2A Q03164 2/20 0.34
FABP2 P12104 1/20 0.34
TSHR P16473 1/20 0.34
AKR1C4 P17516 1/20 0.34
ADRA2B P18089 1/20 0.34
CHRM3 P20309 1/20 0.34
HTR2C P28335 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19804347 0.94 LTB4R (0.39) ALOX5APFEN1LTB4RLTB4R2SLC6A9
SCHEMBL19804344 0.93 ALOX5AP (0.39) ALOX5APFEN1LTB4RLTB4R2SLC6A9
SCHEMBL19804421 0.93 FEN1 (0.43) ALOX5APFEN1LTB4RLTB4R2SLC6A9
SCHEMBL19804544 0.93 LTB4R (0.38) ALOX5APFEN1LTB4RLTB4R2SLC6A9
SCHEMBL19796669 0.92 ALOX5AP (0.36) ALOX5APFEN1LTB4RLTB4R2
SCHEMBL19804285 0.91 SLC6A9 (0.40) LTB4RLTB4R2SLC6A9EGFRPDE4A
SCHEMBL19804410 0.90 ALOX5AP (0.43) ALOX5APFEN1SLC6A9EGFRPTGS1
SCHEMBL19804288 0.89 EGFR (0.38) LTB4RLTB4R2SLC6A9EGFRPDE4A
SCHEMBL19804454 0.89 RARA (0.39) LTB4RLTB4R2SLC6A9EGFRPDE4A
SCHEMBL19804397 0.89 RARB (0.45) LTB4RLTB4R2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, C1S, AP3D1 ALOX5AP 2507/4885FEN1 2669/4885LTB4R 2415/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.